High‐throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry
- 26 August 2005
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 19 (18) , 2651-2658
- https://doi.org/10.1002/rcm.2110
Abstract
The early detection of potential drug‐drug interactions is an important issue of drug discovery that has led to the development of high‐throughput screening (HTS) methods for potential drug interactions. We developed a HTS method for potential interactions of inhibitory drugs for nine human P450 enzymes using cocktail incubation and tandem mass spectrometry in vitro. This new method involves incubation of two cocktail doses and single cassette analysis. The two cocktail doses in vitro were developed to minimize solvent effects and mutual drug interactions among substrates: cocktail A was composed of phenacetin for CYP1A2, coumarin for CYP2A6, paclitaxel for CYP2C8, S‐mephenytoin for CYP2C19, dextromethorphan for CYP2D6, and midazolam for CYP3A4; and cocktail B was composed of three substrates including bupropion for CYP2B6, tolbutamide for CYP2C9, and chlorzoxazone for CYP2E1. In the incubation study of these cocktails, the reaction mixtures were pooled and simultaneously analyzed using liquid chromatography/tandem mass spectrometry employing a fast gradient. The method was validated by comparing the inhibition data obtained from the incubation of each individual probe substrate alone with data from the new method. The IC50 value of each inhibitor in the cocktail agreed well with that of the individual probe drug as well as with values previously reported in the literature. As a HTS method for potential interactions of the inhibition of these nine P450 enzymes, this new method will be useful in the drug discovery process and for the mechanistic understanding of drug interactions. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 33 references indexed in Scilit:
- Study of inhibition of CYP2A6 by some drugs derived from quinolineJournal of Pharmacy and Pharmacology, 2003
- High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography–tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2003
- Interactions of Herbs with Cytochrome P450Drug Metabolism Reviews, 2003
- High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolitesRapid Communications in Mass Spectrometry, 2000
- Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potentialXenobiotica, 1999
- Life-Threatening Interaction of Mibefradil and β-Blockers With Dihydropyridine Calcium Channel BlockersJAMA, 1998
- Microtiter Plate Assays for Inhibition of Human, Drug-Metabolizing Cytochromes P450Analytical Biochemistry, 1997
- Role of Cytochrome P450 Enzymes in Drug-Drug InteractionsPublished by Elsevier ,1997
- Clinically Important Drug Interactions with AnticoagulantsClinical Pharmacokinetics, 1996
- Terfenadine-Ketoconazole InteractionJAMA, 1993